Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629676 · ClinicalTrials.gov registry record · NA
Virtual Reality Intervention for Patients Undergoing BMT
A NA study of Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05629676: Active NA study of Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
NCT05629676 is a NA study of Bone Marrow Transplant Complications that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 313-participant average among 6 other Bone Marrow Transplant Complications trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05629676, a NA study of Bone Marrow Transplant Complications, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone. The BMT-VR intervention has several components: 1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports. 2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes. 3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care
Primary Outcome
The intervention will be deemed feasible if 60% of eligible patients are enrolled and of those enrolled and randomized to BMT-VR, 60% complete at least 60% of the intervention modules
Conditions Studied
Interventions
- BEHAVIORAL BMT-VR
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-12-20 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What the registry record for NCT05629676 still lists
NCT05629676 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 313-participant average among 6 other Bone Marrow Transplant Complications trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Bone Marrow Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which BMT-VR is the first listed.
NCT05629676 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05629676 about?
NCT05629676 is a clinical study titled "Virtual Reality Intervention for Patients Undergoing BMT". The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigne...
What is the current status of trial NCT05629676?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-12-20. Estimated completion is 2026-12-30.
What conditions does trial NCT05629676 study?
This clinical trial studies the following conditions: Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT05629676?
The interventions under investigation include: BMT-VR (BEHAVIORAL).
Who is sponsoring clinical trial NCT05629676?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05629676 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Transplant Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
RECRUITING · NA
-
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
RECRUITING · NA
-
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
RECRUITING · NA
-
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
ACTIVE NOT RECRUITING · NA
-
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI